VentriNaya
PrivateLast Round
Accelerator
Nov 11, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VentriNaya is a biotechnology company developing scalable, off-the-shelf regenerative gene and cell therapy platforms to treat cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VentriNaya Comparables
Compare VentriNaya with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medera | 84% | |
| Jaan Biotherapeutics | 84% | |
| StemCardia | 82% | |
VentriNaya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 11, 2025 |
VentriNaya Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cure by Deerfield | Accelerator |
| Qatar Development Bank | Accelerator |
| Qatar Investment Authority | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Raised an Accelerator round with Qatar Investment Authority and Cure by Deerfield.
VentriNaya Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VentriNaya's valuation, stock price, and market status.